Increased intestinal absorption of insulin in a micellar solution: water-in-oil-in-water insulin micelles. 1978

M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe

Water-in-oil-in-water (W/O/W) insulin micelles were prepared, and the possibility of insulin absorption in a micellar form was examined. In this preparation, insulin was trapped in oil droplets of oleic acid in glyceryl-alpha-monooleate. (1) W/O/W insulin micelles were absorbed from the ligated jejunal loop of rabbits to the order of 12.3 to 58.5% of the dose given (10 mU/kg body weight) during the 3-h experimental period. (2) Alloxan diabetic rats were treated with intrajejunal administration of W/O/W insulin micelles at a dosage of either 25 or 50 mU/100 g body weight, three times daily for as long as 14 days. During treatment, a significant reduction in the daily excretion of urinary glucose was observed, concomitant with a decrease in fasting blood glucose. Quantitative estimates suggested that the effectiveness of 25 mU/100 g of intrajejunal W/O/W insulin micelles was comparable to that of regular insulin at a dosage of 1 mU/100 g i.m. These results would indicate that W/O/W insulin micelles, when given enterally, are more effective in lowering blood and urinary glucose levels than W/O/W insulin emulsions in which insulin was trapped in oil droplets of triglyceride.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006029 Glycosuria The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
August 1968, Nature,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
May 1967, The Journal of clinical investigation,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
June 2002, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
December 2020, ACS omega,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
October 1994, Journal of pharmaceutical sciences,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
May 2004, Journal of controlled release : official journal of the Controlled Release Society,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
April 1972, Chemical & pharmaceutical bulletin,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
August 1972, The American journal of physiology,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
January 1983, Biopharmaceutics & drug disposition,
M Shichiri, and R Kawamori, and Y Goriya, and M Kikuchi, and Y Yamasaki, and Y Shigeta, and H Abe
April 1972, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!